The Business Research Company offers ” Pharmaceutical API Manufacturing Global Market Report 2021: COVID-19 Growth And Change To 2030″ in its research report store. It is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies. The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by region and by country. It also compares the market’s historic and forecast growth and highlights important trends and strategies that players in the market can adopt.
The pharmaceutical API manufacturing market report describes and explains the global pharmaceutical API manufacturing market and covers 2015 to 2020, termed the historic period, and 2020 to 2025 termed the forecast period, along with further forecasts for the period 2025-2030. The report evaluates the market across each region and for the major economies within each region.
The pharmaceutical active pharmaceutical ingredients (API) manufacturing market consists of sales of pharmaceutical active pharmaceutical ingredients and related services. Active pharmaceutical ingredients are used to produce drugs that treat various diseases such as cardiovascular diseases, rare genetic disorders, infections, metabolic disorders, cancers, respiratory diseases, and others. The active pharmaceutical ingredient is a chemical that is responsible for the pharmacological activity in the living body and is used as a major base for the preparation of drugs.
The global pharmaceutical API manufacturing market is expected to grow from $170.06 billion in 2020 to $177.32 billion in 2021 at a compound annual growth rate (CAGR) of 4.3%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The pharmaceutical active pharmaceutical ingredients (API) manufacturing market is expected to reach $215.9 billion in 2025 at a CAGR of 5%.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Source: Openpr